C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2002
12/19/2002	US20020192668 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/19/2002	US20020192667 Isolation and purification of nucleotide sequences; obtain sample, adsorb to support, wash with buffer, recover nucleotide sequences
12/19/2002	US20020192666 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer
12/19/2002	US20020192665 Compositions and methods for the therapeutic use of an atonal-associated sequence for a gastrointestinal condition
12/19/2002	US20020192661 Method for the direct, exponential amplification and sequencing of DNA molecules and its application
12/19/2002	US20020192660 Reducing effect of regulatory sequences on transcription; obtain nucleotide sequences, detect regulatory sequences, mutate, transfect into cell, culture, monitor adjustment in transcription control
12/19/2002	US20020192658 Biopolymer for use in the detection of preferential particle in sample
12/19/2002	US20020192652 Obtaining a tissue sample of the tumor and non-malignant tissue; isolating mRNA; amplification using primers; determining the amount of HER2-neu mRNA; obtaining a differential HER2-neu epression level; determining
12/19/2002	US20020192651 Method of preventing aggregation of a lipid: nucleic acid complex
12/19/2002	US20020192649 Unimolecular segment amplifiction and sequencing
12/19/2002	US20020192648 Classification of microoganism; obtain nucleotide sequences from microorganism, incubate with primer, amplify, recover nucleotide sequences, electrophorese, evaluate pattern, compare to control, evaluate for similarities
12/19/2002	US20020192647 Diagnostic method
12/19/2002	US20020192646 Detecting malignant transformation of human cells, characterized in that overexpression of products of beta 3, beta 5, beta 8 and/or beta 9 genes, encoding hCG beta subunit, as compared with their expression in nonmalignant cells
12/19/2002	US20020192644 Detection of natural killer receptor; obtain samples, incubate with oligonucleotides, detect bound complexes, presence of complexes indicates receptor
12/19/2002	US20020192643 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders
12/19/2002	US20020192642 Diagnosing stomach cancer in humans; obtain fluid sample, detect Epstein Barr virus, the presence of the virus is an indication of stomach cancer
12/19/2002	US20020192640 Purified active HCV NS2/3 protease
12/19/2002	US20020192639 HCV antigen/antibody combination assay
12/19/2002	US20020192635 Kits for use in monitoring and evaluating cell metabolism
12/19/2002	US20020192237 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis, and bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions
12/19/2002	US20020192232 Methods and compositions for impairing multiplication of HIV-1
12/19/2002	US20020192230 Therapeutic formulations using heat shock/stress protein-peptide complexes
12/19/2002	US20020192228 Protein markers for lung cancer and use thereof
12/19/2002	US20020192226 Production of a parvovirus vaccine in plants as viral coat protein fusions
12/19/2002	US20020192225 Methods of identifying bacterial genes that are incompatible with bacterial pathogenicity, and the use of such genes, such as cadA, to reduce pathogenicity in a bacteria or to combat pathogenic bacterial infections
12/19/2002	US20020192223 Novel antibody conjugates reactive with human carcinomas
12/19/2002	US20020192220 Compositions and methods relating to colon specific genes and proteins
12/19/2002	US20020192219 Morphogenic proteins
12/19/2002	US20020192218 Oncoprotein protein kinase
12/19/2002	US20020192217 Methods for regulation of immune responses to conditions involving mediator-induced pathology
12/19/2002	US20020192216 Therapeutic use
12/19/2002	US20020192214 Eosinophil eotaxin receptor
12/19/2002	US20020192204 15985, a novel human serine/threonine protein kinase family member and uses thereof
12/19/2002	US20020192199 Composition and methods for enhanced tumor cell immunity in vivo
12/19/2002	US20020192195 Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment
12/19/2002	US20020192193 Antigen presenting cells, a process for preparing the same and their use as cellular vaccines
12/19/2002	US20020192192 Antigen presenting cells, a process for preparing the same and their use as cellular vaccines
12/19/2002	US20020192189 AAV transduction of myoblasts
12/19/2002	US20020192188 Use of recombinant adeno-associated virus vector (rAAV) for the prevention of smooth muscle cell proliferation in a vascular graft
12/19/2002	US20020192187 Gene transfer with adenoviruses having modified fiber proteins
12/19/2002	US20020192186 Gene therapy for pulmonary edema using adenovirus vectors encoding Na,K-ATPase
12/19/2002	US20020192185 Recombinant protein production in bovine adenovirus expression vector system
12/19/2002	US20020192160 Novel human tumor suppressor gene
12/19/2002	US20020191826 Polymerase chain reaction system
12/19/2002	US20020189948 Electrophoresis separation media and methods
12/19/2002	DE10140030C1 Method for performing multiple recombination events in a genetic system, useful e.g. for removing antibiotic resistance genes, uses mutant recombinase recognition sites
12/19/2002	DE10129010A1 Producing a transgenic plant or plant cell expressing a transgene under control of native transcription and translation elements already present in the genome is useful to give stable expression of transgenes
12/19/2002	DE10128780A1 Production of D-pantothenic acid, optionally as salt and/or contained in feed additive, by fermenting Enterobacteriaceae strain in which specific nucleotide sequences have been amplified
12/19/2002	DE10128510A1 New nucleic acid array useful for monitoring mRNA expression of Corynebacterium glutamicum during fermentation, comprising nucleic acid from Corynebacterium glutamicum
12/19/2002	DE10128400A1 New oligonucleotides are useful to detect filamentous bacteria in samples, particularly in activated sludge
12/19/2002	DE10125839A1 Regulating gene expression and viral replication by switching off an active mutated promoter of a repressor allows selective expression of therapeutic genes and viral vectors in tumor cells
12/19/2002	CA2465884A1 Transgenic plants synthesising high amylose starch
12/19/2002	CA2462173A1 Method for rapid amplification of dna
12/19/2002	CA2450752A1 Method for specific, fast detection of threadlike bacteria
12/19/2002	CA2450671A1 Method for assessing the virulence of pathogens and uses thereof
12/19/2002	CA2450669A1 Anti-apoptosis genes and methods of use thereof
12/19/2002	CA2450665A1 Processes and vectors for producing transgenic plants
12/19/2002	CA2450403A1 Complete mitochondrial genome sequences as a diagnostic tool for the health sciences
12/19/2002	CA2450389A1 Cyp450-specific dna probes and primers, and biological applications thereof
12/19/2002	CA2450379A1 Molecular signatures of commonly fatal carcinomas
12/19/2002	CA2450320A1 Dna sequencing method
12/19/2002	CA2450319A1 Mutant rna polymerases
12/19/2002	CA2450285A1 Human monoclonal antibodies to epidermal growth factor receptor (egfr)
12/19/2002	CA2450113A1 Vanilloid receptor-related nucleic acids and polypeptides
12/19/2002	CA2450027A1 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
12/19/2002	CA2450022A1 Method of testing drug for treating or preventing diseases such as hyperlipemia
12/19/2002	CA2450019A1 Production of proteins in plants
12/19/2002	CA2449934A1 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
12/19/2002	CA2449920A1 Modifying nicotine and nitrosamine levels in tobacco
12/19/2002	CA2449687A1 Vascular regeneration therapy
12/19/2002	CA2449661A1 Method for obtaining a monocotyledon plant containing a gene of interest free of foreign ancillary sequence
12/19/2002	CA2449649A1 A g-protein coupled receptor and uses therefor
12/19/2002	CA2449602A1 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
12/19/2002	CA2449598A1 Conjugated linoleic acid isomerase and a process for the production of conjugated linoleic acid
12/19/2002	CA2449591A1 Brain expressed gene and protein associated with bipolar disorder
12/19/2002	CA2449589A1 Gene transfer into primate embryonic stem cells using vsv-g pseudotyped simian immunodeficiency virus vector
12/19/2002	CA2449560A1 Low-temperature cycle extension of dna with high priming specificity
12/19/2002	CA2449553A1 Non-endogenous, constitutively activated versions of plant g protein-coupled receptor: gcr1
12/19/2002	CA2449517A1 Tissue-specific endothelial membrane proteins
12/19/2002	CA2449440A1 Structural and cytoskeleton-associated proteins
12/19/2002	CA2449279A1 A mouse unable to express functional alpha-4 integrin protein, and methods for assaying compounds or agents for alpha-4 integrin protein antagonist activity and a genetic marker for evaluating efficacy of modulators of signaling activity of a vla-4 receptor
12/19/2002	CA2449272A1 Intracellular signaling molecules
12/19/2002	CA2449259A1 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same
12/19/2002	CA2449085A1 A method for altering the isoflavonoid profile in the plant parts of an isoflavonoid-producing plant
12/19/2002	CA2448432A1 Purification of human serum albumin
12/19/2002	CA2448289A1 Method of constructing host and method of producing heterologous protein
12/19/2002	CA2447791A1 Methods of culturing animal cells and polypeptide production in animal cells
12/19/2002	CA2447658A1 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines
12/18/2002	EP1267295A1 A method and system for analyzing gene expression data using a smooth response surface algorithm
12/18/2002	EP1267273A2 Interactive optical storage medium having preloaded font information, and apparatus and method for reproducing data from interactive optical storage medium
12/18/2002	EP1267171A1 Cofactor-based screening method for nuclear receptor modulators
12/18/2002	EP1266970A2 Detecting nucleic acid deletion sequences
12/18/2002	EP1266969A1 Method for detecting dechlorination bacteria and method for treating earth or underground water polluted by chlorinated ethylene or chlorinated ethane, and nucleic acids used in the methods
12/18/2002	EP1266966A2 Method for producing L-lysine or L-arginine by using methanol assimilating bacterium
12/18/2002	EP1266965A2 Recombinant antibodies for human therapy
12/18/2002	EP1266964A1 Precursors of silk-like materials, silk-like materials and processes for producing both
12/18/2002	EP1266963A1 Chimaeric phages
12/18/2002	EP1266907A1 67108, a Human phospholipid transporter family member and uses therefor
12/18/2002	EP1266906A1 46584, a human transporter family member and uses therefor
12/18/2002	EP1266385A2 Porous ferro- or ferrimagnetic glass particles for isolating molecules

1 ... 2635 2636 2637 2638 2639 2640 2641 2642 2643 2644 2645 2646 2647 2648 2649 2650 2651 2652 2653 2654 2655 ... 4023